PT - JOURNAL ARTICLE AU - Geng, Yibo AU - Xie, Luyang AU - Wang, Yang AU - Wang, Yan TI - Unveiling the oncogenic significance of thymidylate synthase in human cancers AID - 10.1101/2024.01.05.24300913 DP - 2024 Jan 01 TA - medRxiv PG - 2024.01.05.24300913 4099 - http://medrxiv.org/content/early/2024/01/07/2024.01.05.24300913.short 4100 - http://medrxiv.org/content/early/2024/01/07/2024.01.05.24300913.full AB - Background Thymidylate synthase (TYMS) constitutes a pivotal and potent target in the context of chemoresistance. However, the oncogenic role of TYMS has received insufficient attention.Methods Leveraging data from the Cancer Genome Atlas and various public databases, we conducted an extensive investigation into the oncogenic role of TYMS across 33 cancer types.Results TYMS exhibited pronounced expression across a spectrum of cancers and demonstrated associations with clinical outcomes in diverse cancer patient cohorts. Furthermore, genetic alterations were identified as potential influencers of overall survival in specific tumor types. Notably, the expression of thymidylate synthase correlated with tumor-infiltrating CD4+ cells in select cancers. Additionally, the functional mechanism of TYMS encompassed nucleotidase activity, chromosome segregation, and DNA replication progress.Conclusions This study furnishes a comprehensive understanding of the oncogenic role played by TYMS in human tumors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Beijing Municipal Natural Science Foundation (No. 7244344), Beijing Chao-yang Hospital Golden Seed foundation (No. CYJZ202201) and the inner-hospital foundation of Beijing Chao-yang Hospital. Besides, we would like to thank Xulei Huo for his technical supports.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authorsACCAdrenocortical carcinomaBLCABladder Urothelial CarcinomaBRCABreast invasive carcinoma Cervical squamous cell carcinoma and endocervicalCESCadenocarcinomaCHOLCholangiocarcinomaCOADColon adenocarcinomaDFSDisease free survivalDLBCDiffuse Large B-cell LymphomadTMPdeoxythymidine monophosphateESCAEsophageal carcinomaGBMGlioblastomaGEPIA2Gene Expression Profiling Interactive Analysis, version 2GTExGenotype-Tissue ExpressionHNSCHead and Neck squamous cell carcinomaHPAThe Human Protein AtlasIHCImmunohistochemistryKICHKidney ChromophobeKIRCKidney renal clear cell carcinomaKIRPKidney renal papillary cell carcinomaLAMLAcute Myeloid LeukemiaLGGLow grade gliomaLIHCLiver hepatocellular carcinomaLUADLung adenocarcinomaLUSCLung squamous cell carcinomaMESOMesotheliomaMHCmajor histocompatibility complexNCBINational Center for Biotechnology InformationNKNatural killerNSCLCnon-small cell lung carcinomaOSOverall survivalOVOvarian serous cystadenocarcinomaPAADPancreatic adenocarcinomaPCPGPheochromocytoma and ParagangliomaPRADProstate adenocarcinomaREADProstate adenocarcinomaSARCSarcomaSKCMSkin Cutaneous MelanomaSTADStomach adenocarcinomaTCGAThe cancer genome atlasTGCTTesticular Germ Cell TumorsTHCATesticular Germ Cell TumorsTHYMThymomaTIMER2tumor immune estimation resource, version 2TPMTranscripts per millionTYMSthymidylate synthaseUCECUterine Corpus Endometrial CarcinomaUCSUterine CarcinosarcomaUVMUveal Melanoma